Meropenem Injection, Powder, For Solution
Product Images NDC 25021-161

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Meropenem (NDC 25021-161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Mer0f 0000 01)

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Mer0f 0000 02)

Package Label – Principal Display Panel – Vial Label (Mer0f 0000 02)
This text appears to be a label or accompanying information for a medication vial of Meropenem Injection, USP. It indicates that the vial contains 500 mg of Meropenem and provides the National Drug Code (NDC) as 25021-160-20. The text also includes instructions to discard any unused portion.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Mer0f 0000 03)

Package Label – Principal Display Panel – Vial Label (Mer0f 0000 03)
This is not-readable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.